07/27/2022

Using Molecular Signatures of Pancreatic Ductal Adenocarcinoma (PDAC) for Targeting Discovery

A real-world example of how the Tempus multimodal database supported a large pharmaceutical organization with target discovery in subtypes of pancreatic cancer.